透景生命：关于对外投资参股公司的公告

Core Viewpoint - The company, TuoJing Life, has announced a strategic investment in Huihe Biotechnology, acquiring a 9.2141% stake through a capital increase agreement totaling RMB 68 million [2] Group 1: Investment Details - TuoJing Life signed multiple agreements with Huihe Biotechnology and other parties for the capital increase [2] - The investment involves subscribing to an additional registered capital of RMB 175,992 [2] - The transaction does not require approval from the company's board or shareholders [2]